Press Release | NeoGenomics Laboratories

February 5, 2020

NeoGenomics Announces Leadership Appointments

January 10, 2020

NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million

December 6, 2019

EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas

November 6, 2019

NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference

October 29, 2019

NeoGenomics Reports 51% Revenue Growth to $105 Million in the Third Quarter

October 1, 2019

NeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019

September 25, 2019

NeoGenomics To Present At 2019 Cantor Global Healthcare Conference

September 3, 2019

NeoGenomics to Participate in Two Upcoming September Institutional Investor Conferences

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients